California 2025-2026 Regular Session

California Assembly Bill AB1394

Introduced
2/21/25  
Refer
3/24/25  
Report Pass
3/24/25  
Refer
3/25/25  
Refer
3/24/25  
Report Pass
4/1/25  
Report Pass
3/24/25  
Refer
4/2/25  
Refer
3/25/25  
Refer
3/25/25  
Report Pass
4/1/25  
Report Pass
4/1/25  
Refer
4/2/25  

Caption

Personal opioid drug deactivation and disposal systems.

Companion Bills

No companion bills found.

Similar Bills

MI SB0003

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

MA H2217

Relative to opioid reversal drugs

OR HB3613

Relating to pharmaceutical purchasing; prescribing an effective date.

VA HB1905

Compounding drugs; exceptions for distribution within hospital or health system.

VA SB1366

Compounding drugs; exceptions for distribution within hospital or health system.

KS SB212

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

CA AB1474

Health care cost targets.

MI HB5078

Health: pharmaceuticals; distribution of opioid antagonists by employees and agents of agencies under the administration of opioid antagonists act; provide for. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).